期刊文献+

维持性血液透析和维持性腹膜透析患者脂代谢特征及其与营养状况关系的临床研究 被引量:9

下载PDF
导出
摘要 目的:比较维持性血液透析(MHD)和维持性腹膜透析(CAPD)患者脂代谢紊乱的异同,探讨各自脂代谢紊乱的特征及其与营养状况的关系。方法:选取2009年7月~2009年10月门诊行MHD的124例患者和行CAPD的65例患者为研究对象。观察指标包括:(1)脂代谢指标:包括胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)、载脂蛋白A(Apo-A)和载脂蛋白B(Apo-B);(2)营养指标:包括营养不良炎症评分(MIS)、肱三头肌皮褶厚度(TSF)、中臂围(MAC)、中臂肌围(AMC)和血清白蛋白(Alb)。结果:(1)MHD患者高TG的发生率为25%,低HDL和低Apo-A发生率分别为72.58%和67%;CAPD组高TC、TG、LDL发生率分别为32.31%、38.46%和35.38%,低LDL、HDL和Apo-A发生率分别为43.08%、73.85%和55.38%;(2)CAPD组的TC、TG、LDL和Apo-A均高于MHD组,差异有统计学意义(P<0.05)。(3)MHD组MIS低于CAPD组,差异有统计学意义(P<0.05);MHD组MAC、MAMC和Alb高于CAPD组,差异有统计学意义(P<0.05),两组间TSF差异无统计学意义(P>0.05)。(4)MHD组TG、HDL和Apo-A与MIS显著负相关(P<0.05),与Alb和HDL显著正相关(P<0.05)。PD组脂代谢指标与MIS和Alb等营养指标无相关性(P>0.05)。结论:脂代谢紊乱是MHD和CAPD患者常见的并发症。MHD患者脂代谢紊乱的特征是高TG、低HDL和低Apo-A,而高TC却不常见。CAPD患者脂代谢紊乱特征是高TC、高TG和高LDL并存,低LDL、低HDL和低Apo-A并存。CAPD患者脂代谢紊乱和营养不良较MHD患者严重。TG、HDL和Apo-A是可用来评价MHD患者营养状况的指标,而脂代谢指标不能放映PD患者的营养状况。
出处 《中国中西医结合肾病杂志》 2010年第3期229-231,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 浙江省温岭市科技计划基金资助项目(No.2009WLCB0085)
  • 相关文献

参考文献12

  • 1Kalantar-Zadeh K,Kopple JD,Humphreys MH,et al.Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients.Nephrol Dial Transplant,2004,19(6):1507-1519.
  • 2Kalantar-Zadeh K,Kopple JD,Block G,et al.A malnutritioninflammation score is correlated with motbidity and nortality in mainteance hemodialysis patients.Am J Kidney Dis,2001,38 (6):1251-1263.
  • 3Chan JY,Che KI,Lam KM,et al.Comprehensive malnutrition inflammation score as a marker of nutritional status in Chinese peritoneal dialysis patients.Nephrology (Carlton),2007,12(2):130-134.
  • 4Beddhu S,Pappas LM,Ramkunar N,et al.Effects of body size and body composition on survival in hemodialysis patients.J Am Soc Nephrol,2003,14(9):2366-2372.
  • 5Joven J,Vilella E,Ahmad S,et al.Lipoptotein heterogenneity in end-stage renal failure disease.Kidney Int,1993,43(2):410-418.
  • 6Weintraub M,Rassin T,Eisenberg S,et al.Continuous intravenous heparin administration in humaans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation.J Lipid Res,1994,35(2):229-238.
  • 7郭彦聪,张凌.低分子肝素对血液透析患者脂代谢影响的回顾性分析[J].中国血液净化,2003,2(6):311-314. 被引量:11
  • 8Morrison G.Metabolic effects of continuous ambulatory peritoneal dialysis.Ann Rev Med,1989,40:163-172.
  • 9袁伟杰 叶志斌 金惠敏 北京.肾脏病营养治疗学[J].中国中医药科技,2000,:34-34.
  • 10Kalantar-Zadeh K,Block G,Humphreys MH.Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.Kidney Int,2003,63 (3):793-808.

二级参考文献12

  • 1[1]Arnadottir M,Kurkus J,Nilsson EP. Different types of heparin in hemeodialysis: long term effects on post-heparin lipases. Scard J Clin Lab Invest,1994,54:515-521
  • 2[2]Bergvist D.Low molecular weight heparins.J Intern Med ,1996,240:63-72
  • 3[3]Stefoni S, Cianciolo G, Donati G et al. Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis. Nephron, 2002,92(3):589-600
  • 4[4]Lai KN, Ho K, Cheung RC et al. Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis. Int J Artif Organs, 2001, 24(7):447-55
  • 5[5]Stenvinkel P.Low molecular weight heparin:Does it favourably affect lipid levels?Nephrol Dial Transplant,1995,19:16
  • 6[6]Weintraub M,Rassin T,Eisenberg S, et al.Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation.J Lipid Res,1994,35:229
  • 7[7]Yang C,Wu T,Huang C,et al.Low molecular weight heparin reduces triglyceride,VLDL and cholesterol/HDL levels in hyperlipidemic diabetic patients on hemodialysis.Am J Nephrol,1998,18(5):384
  • 8[8]Elisaf MS,Germanos NP,Bairaktari HT,et al.Effects of conventional vs low-molecularweight heparin on lipid profil in hemodialysis patients.Am J Nephrol,1997,17(2):153
  • 9[9]Kronenberg F,Konig P,Neyer U,et al.Influence of various heparin preparation on lipoproteins in hemodialysis patients:a multicentre study.Thromb Haemost,1995,74(4):1025
  • 10[10]Kronenberg F,Konig Pm,Lhotta K,et al.Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.Clin Nephrol,1995,43:399

共引文献10

同被引文献104

引证文献9

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部